abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: what is offered is using 40-O-(2-hydroxyethyl)rapamycin for preparing a pharmaceutical composition for treating a renal tumour representing carcinoma. n EFFECT: 40-O-(2-hydroxyethyl)rapamycin twice reduces tumour growth time or death rate of the patients with advanced renal cell carcinoma. n 1 tbl |